Lymphoplasmacytic lymphoma: Difference between revisions
Sara Mohsin (talk | contribs) No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{S.M.}} | {{CMG}}; {{AE}} {{S.M.}} | ||
{{SK}} | {{SK}} [[Plasmacytoid lymphocytic lymphoma]]; [[Familial]] [[Waldenström's macroglobulinemia|Waldenstrom's Macroglobulinemia]] Primary [[macroglobulinemia]]; [[Hyperviscosity syndrome]]; Lymphoplasmacytoid [[lymphoma]] | ||
==[[Lymphoplasmacytic lymphoma overview|Overview]]== | ==[[Lymphoplasmacytic lymphoma overview|Overview]]== |
Revision as of 18:48, 31 August 2019
Lymphoplasmacytic lymphoma Microchapters |
Differentiating Lymphoplasmacytic Lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Lymphoplasmacytic lymphoma On the Web |
American Roentgen Ray Society Images of Lymphoplasmacytic lymphoma |
Risk calculators and risk factors for Lymphoplasmacytic lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Synonyms and keywords: Plasmacytoid lymphocytic lymphoma; Familial Waldenstrom's Macroglobulinemia Primary macroglobulinemia; Hyperviscosity syndrome; Lymphoplasmacytoid lymphoma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphoplasmacytic lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies